ClinicalThought

Share

Program Content

Activities

  • FAQs: Novel Tx GynOnc
    FAQs: Integrating Novel Therapies Into the Management of Gynecologic Cancers
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 23, 2022

    Expires: May 22, 2023

  • GynOnc: Sequencing Therapy
    Selecting and Sequencing New Treatment Strategies in Gynecologic Cancers
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 05, 2022

    Expires: July 04, 2023

  • Ovarian Cancer: ESMO Updates
    Practical Considerations for Using PARP Inhibitors in Ovarian Cancer: Key ESMO Congress Updates
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 19, 2022

    Expires: October 18, 2023

  • IGCS 2022: Cervical, Ovarian
    Key Updates in Cervical and Ovarian Cancers: IGCS 2022 Annual Meeting
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 03, 2022

    Expires: November 02, 2023

  • 2022 ESGO: Key Data
    2022 ESGO Congress: Experts Discuss HRD Testing, PARP Inhibitors in Recurrent Ovarian Cancer, and QoL in Nonepithelial Ovarian Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 02, 2022

    Expires: December 01, 2023

Provided by

ProCE Banner

Supporters

AstraZeneca

GlaxoSmithKline

Karyopharm Therapeutics Inc.

Merck Sharp & Dohme Corp.